MYM Nutraceuticals Inc, (CSE: MYM) (OTCBB: MYMMF), a Canada-based company focused on the global growth of Cannabis and CBD-rich hemp, has named its current executives, Mark Forster and Paul Cheetham, as CFO and COO respectively of MYM International Brands Inc, it is reported today.
Both executives have transferred from MYM Nutraceuticals to the International Brands team to launch global expansion efforts of CBD-rich consumer products in a wide variety of categories, including food and beverage, pharmaceuticals, cosmetics, and health and wellness.
The company has also requested one of its present independent directors, Andrew Kent, to offer assistance by serving on the board of International Brands as an independent director, and accordingly he will step down as an independent director of the company while in that new capacity.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer